| __timestamp | Exelixis, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 189101000 | 1488000000 |
| Thursday, January 1, 2015 | 96351000 | 1525000000 |
| Friday, January 1, 2016 | 95967000 | 2111000000 |
| Sunday, January 1, 2017 | 112171000 | 1848000000 |
| Monday, January 1, 2018 | 182257000 | 1213000000 |
| Tuesday, January 1, 2019 | 336964000 | 1010000000 |
| Wednesday, January 1, 2020 | 547851000 | 997000000 |
| Friday, January 1, 2021 | 693716000 | 967000000 |
| Saturday, January 1, 2022 | 891813000 | 838000000 |
| Sunday, January 1, 2023 | 1044071000 | 953000000 |
| Monday, January 1, 2024 | 910408000 | 998000000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Teva Pharmaceutical Industries Limited and Exelixis, Inc. have shown contrasting approaches to R&D investment. From 2014 to 2023, Teva's R&D expenses have fluctuated, peaking in 2016 with a 2.1 billion USD investment, while Exelixis has steadily increased its R&D spending, culminating in a 1.04 billion USD investment in 2023. This represents a remarkable 447% increase for Exelixis over the period, compared to a 36% decrease for Teva. These trends highlight Exelixis's growing focus on innovation, potentially positioning it as a future leader in pharmaceutical advancements. As the industry evolves, monitoring these investments will be crucial for stakeholders aiming to understand the future landscape of pharmaceutical innovation.
AstraZeneca PLC or Exelixis, Inc.: Who Invests More in Innovation?
R&D Insights: How Takeda Pharmaceutical Company Limited and Exelixis, Inc. Allocate Funds
Teva Pharmaceutical Industries Limited or Intra-Cellular Therapies, Inc.: Who Invests More in Innovation?
Key Insights on Gross Profit: Teva Pharmaceutical Industries Limited vs Exelixis, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Jazz Pharmaceuticals plc
R&D Spending Showdown: Teva Pharmaceutical Industries Limited vs PTC Therapeutics, Inc.
United Therapeutics Corporation vs Exelixis, Inc.: Strategic Focus on R&D Spending
Summit Therapeutics Inc. vs Exelixis, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: BioMarin Pharmaceutical Inc. and Exelixis, Inc.
Research and Development Investment: Exelixis, Inc. vs Alpine Immune Sciences, Inc.
Exelixis, Inc. or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Exelixis, Inc. vs Viridian Therapeutics, Inc.